Adenosine vs Diltiazem for SVT in the emergency room
Part of Heart & circulation clinical trials.
This study compares two medications, adenosine and diltiazem, to see which works better for treating a rapid heart rhythm called SVT (supraventricular tachycardia) in the emergency department. If you have a stable episode of SVT, this trial may help doctors find the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are diagnosed with stable SVT (a fast heart rhythm) in the emergency department
- You have not received any IV heart rhythm medication for this episode before joining the study
- You do not have a history of Wolff-Parkinson-White syndrome (WPW, a specific heart condition)
- You do not have heart failure with a weak pump (ejection fraction less than or equal to 40%)
- You are not pregnant, not incarcerated, and have not been in this study before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how patients feel about two common medicines (adenosine and diltiazem) used to treat a fast heart rhythm called SVT in the emergency department. If you were treated for SVT in the ER, you may be able to share your experience through a survey.
This trial compares two medicines, adenosine and verapamil, to see which works better for stopping a sudden fast heart rhythm called SVT. If you have an episode of SVT that is stable enough to not need emergency shock treatment, you may be able to join.
This trial tests two different medicines to slow a rapid heartbeat caused by atrial fibrillation or flutter. You will receive either an oral pill (bisoprolol) or intravenous (IV) medication (diltiazem) to see which works better and faster.
This trial compares two common heart medicines (verapamil and metoprolol) to see which works better for people with a fast, irregular heartbeat called atrial fibrillation. If you come to the Emergency Department with a heart rate of 110 or more and are stable, you may be able to join.
This trial looks at two common types of supraventricular tachycardia (SVT): AVNRT and AVRT. The goal is to tell them apart better, which can guide treatment.
This study compares two medications (atenolol and ivabradine) to see which one better controls a fast heart rate (tachycardia) in people with treatment-resistant schizophrenia who are taking clozapine. The goal is to find a safer way to manage this side effect.
Hear when a new Supraventricular Tachycardia (SVT) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.